Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
…, E Wynberg, BJ Verkaik, OJA Figaroa… - Elife, 2021 - elifesciences.org
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
Positioning the role of urine cytology within the diagnostic pathway for UTUC: supportive but inconclusive
OJA Figaroa, N Hendriks, GM Kamphuis… - World Journal of …, 2023 - Springer
Purpose With the introduction of kidney-sparing surgery (KSS) for low-risk Upper Tract
Urothelial Carcinoma (UTUC), correct risk-stratification has become crucial. High-grade cytology …
Urothelial Carcinoma (UTUC), correct risk-stratification has become crucial. High-grade cytology …
[HTML][HTML] One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset
…, A Verveen, M Dijkstra, BJ Verkaik, OJA Figaroa… - Plos one, 2023 - journals.plos.org
Background There is increasing data that show a persistently impaired pulmonary function
upon recovery after severe infection. Little is known however about the extent, recovery and …
upon recovery after severe infection. Little is known however about the extent, recovery and …
[HTML][HTML] Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data
OJA Figaroa, N Hendriks, GM Kamphuis… - European Urology …, 2023 - Elsevier
… Author contributions: Orlane JA Figaroa had full access to all the data in the study and
takes responsibility for the integrity of the data and the accuracy of the data analysis. …
takes responsibility for the integrity of the data and the accuracy of the data analysis. …
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination (preprint)
…, E Wynberg, BJ Verkaik, OJA Figaroa… - 2021 - pesquisa.bvsalud.org
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
Prognostic factors for renal cell carcinoma subtypes diagnosed according to the 2016 WHO renal tumor classification: a study involving 928 patients
L Kuthi, A Jenei, A Hajdu, I Németh, Z Varga… - Pathology & Oncology …, 2017 - Springer
The morphotype and grade of renal cell carcinoma (RCC) in 928 nephrectomies were
reclassified according to the 2016 WHO classification in order to analyze the distribution and …
reclassified according to the 2016 WHO classification in order to analyze the distribution and …
Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma
Background A recently reported phase III randomized trial comparing open and minimally
invasive hysterectomy showed significantly higher rates of local recurrence after minimally …
invasive hysterectomy showed significantly higher rates of local recurrence after minimally …
[HTML][HTML] Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a …
C Kesch, V Pantea, T Soeterik, A Marquis… - World Journal of …, 2023 - Springer
Purpose Although active surveillance (AS) is recommended for low- to favorable intermediate-risk
prostate cancer (PCa), risk of upgrading at radical prostatectomy (RP) is not negligible…
prostate cancer (PCa), risk of upgrading at radical prostatectomy (RP) is not negligible…
Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a …
L Boeri, M Soligo, I Frank, SA Boorjian… - World Journal of …, 2019 - Springer
Purpose To investigate the prevalence of and factors’ association with receiving suboptimal
neoadjuvant chemotherapy (NAC) and its impact on survival outcomes in patients with …
neoadjuvant chemotherapy (NAC) and its impact on survival outcomes in patients with …
[CITATION][C] One-Fourth of COVID-19 Patients Have an Impaired Pulmonary Function after 12 Months of Illness Onset (preprint)
…, A Verveen, M Dijkstra, BJ Verkaik, OJA Figaroa… - 2023 - pesquisa.bvsalud.org
… Verkaik; Orlane JA Figaroa; Marianne C. de Jong; Annelou van Veen; Agata Makowska;
Nelleke Koedoot; Pythia T. Nieuwkerk; Anders Boyd; Maria Prins; Godelieve J. …
Nelleke Koedoot; Pythia T. Nieuwkerk; Anders Boyd; Maria Prins; Godelieve J. …
